Previous 10 | Next 10 |
Rockwell Medical, Inc. (RMTI) Q2 2021 Earnings Conference Call August 16, 2021 4:30 PM ET Company Participants Jason Finkelstein - Investor Relations, Argot Partners Russell Ellison - President & Chief Executive Officer Russell Skibsted - Executive Vice President, Chief Financial Officer ...
-Entered into exclusive license agreement with Drogsan Pharmaceuticals for the rights to commercialize Triferic ® in Turkey- -Extended multi-year distribution agreement with Nipro Medical for dialysis concentrates in LATAM and the Caribbean- -Q2 2021 conference ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There have been plenty of improvement in key economic indicators of late. Core inflation has found calm while the jobs market is recovering, which has inspired a positive outlook from most analysts. As a rule of thumb, smal...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
WIXOM, Mich., July 29, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it will host a confe...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Shares of Rockwell Medical Inc. (NASDAQ:RMTI) traded at a new 52-week low today of $0.75. This new low was reached on below average trading volume as 383,000 shares traded hands, while the average 30-day volume is approximately 1.5 million shares. Rockwell Medical Inc is a US-based fully...
Shares of Rockwell Medical Inc. (NASDAQ:RMTI) traded at a new 52-week low today of $0.75. Approximately 383,000 shares have changed hands today, as compared to an average 30-day volume of 1.5 million shares. There is potential upside of 36.5% for shares of Rockwell Medical Inc. based on ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Shares of Rockwell Medical Inc. (NASDAQ:RMTI) traded at a new 52-week low today of $0.81. This new low was reached on below average trading volume as 383,000 shares traded hands, while the average 30-day volume is approximately 1.3 million shares. Potential upside of 23.5% exists for Roc...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...